AU2009214533B2 - Implantable products comprising nanoparticles - Google Patents

Implantable products comprising nanoparticles Download PDF

Info

Publication number
AU2009214533B2
AU2009214533B2 AU2009214533A AU2009214533A AU2009214533B2 AU 2009214533 B2 AU2009214533 B2 AU 2009214533B2 AU 2009214533 A AU2009214533 A AU 2009214533A AU 2009214533 A AU2009214533 A AU 2009214533A AU 2009214533 B2 AU2009214533 B2 AU 2009214533B2
Authority
AU
Australia
Prior art keywords
cancer
medical product
medical
particles
carcinoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2009214533A
Other languages
English (en)
Other versions
AU2009214533A1 (en
Inventor
Andreas Jordan
Burghard Thiesen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanotherm Therapeutics GmbH
Original Assignee
Nanotherm Therapeutics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanotherm Therapeutics GmbH filed Critical Nanotherm Therapeutics GmbH
Publication of AU2009214533A1 publication Critical patent/AU2009214533A1/en
Assigned to MAGFORCE AG reassignment MAGFORCE AG Alteration of Name(s) of Applicant(s) under S113 Assignors: MAGFORCE NANOTECHNOLOGIES AG
Application granted granted Critical
Publication of AU2009214533B2 publication Critical patent/AU2009214533B2/en
Assigned to Nanotherm Therapeutics GmbH reassignment Nanotherm Therapeutics GmbH Request for Assignment Assignors: MAGFORCE AG
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Composite Materials (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
AU2009214533A 2008-02-11 2009-02-11 Implantable products comprising nanoparticles Active AU2009214533B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE102008008522A DE102008008522A1 (de) 2008-02-11 2008-02-11 Implantierbare Nanopartikel-enthaltende Produkte
DE102008008522.7 2008-02-11
US7108408P 2008-04-11 2008-04-11
US61/071,084 2008-04-11
PCT/DE2009/000196 WO2009100716A2 (de) 2008-02-11 2009-02-11 Implantierbare nanopartikel-enthaltende produkte

Publications (2)

Publication Number Publication Date
AU2009214533A1 AU2009214533A1 (en) 2009-08-20
AU2009214533B2 true AU2009214533B2 (en) 2015-01-29

Family

ID=40847365

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2009214533A Active AU2009214533B2 (en) 2008-02-11 2009-02-11 Implantable products comprising nanoparticles

Country Status (18)

Country Link
US (1) US20110223255A1 (enExample)
EP (1) EP2249804B1 (enExample)
JP (1) JP5649455B2 (enExample)
KR (1) KR101581973B1 (enExample)
CN (1) CN101938993A (enExample)
AU (1) AU2009214533B2 (enExample)
BR (1) BRPI0906611A8 (enExample)
CA (1) CA2712832C (enExample)
DE (2) DE102008008522A1 (enExample)
DK (1) DK2249804T3 (enExample)
ES (1) ES2619509T3 (enExample)
IL (1) IL207137A (enExample)
MX (1) MX2010008806A (enExample)
PL (1) PL2249804T3 (enExample)
PT (1) PT2249804T (enExample)
RU (1) RU2524644C2 (enExample)
SG (1) SG188146A1 (enExample)
WO (1) WO2009100716A2 (enExample)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007070660A2 (en) 2005-12-13 2007-06-21 President And Fellows Of Harvard College Scaffolds for cell transplantation
CA2715460C (en) 2008-02-13 2020-02-18 President And Fellows Of Harvard College Continuous cell programming devices
US20110165255A1 (en) * 2008-09-04 2011-07-07 Takeshi Kobayashi Malignant tumor heat therapy kit comprising anti-regulatory t cell antibody and magnetic fine particles and heat therapy method thereof
JP5463531B2 (ja) * 2009-07-22 2014-04-09 国立大学法人 東京大学 Ｐｈｄ２発現抑制物質搭載ポリイオンコンプレックス
AU2010278702C1 (en) 2009-07-31 2016-07-14 Forsyth Dental Infirmary For Children Programming of cells for tolerogenic therapies
EP2322142B1 (de) * 2009-11-12 2016-07-27 Helmholtz-Zentrum Geesthacht Zentrum für Material- und Küstenforschung GmbH Biokompatible, magnetische Nanopartikel zur Behandlung von Glioblastomen
DE102009058769A1 (de) * 2009-12-16 2011-06-22 MagForce Nanotechnologies AG, 10589 Temperaturabhängige Aktivierung von katalytischen Nukleinsäuren zur kontrollierten Wirkstofffreisetzung
US20130089740A1 (en) * 2010-06-29 2013-04-11 Koninklijke Philips Electronics N.V. Synthesis and use of iron oleate
JP5945540B2 (ja) 2010-08-27 2016-07-05 シエナ バイオファーマシューティカルズ，インク． 標的とされた熱変調のための組成物及び方法
US9572880B2 (en) 2010-08-27 2017-02-21 Sienna Biopharmaceuticals, Inc. Ultrasound delivery of nanoparticles
HRP20200310T1 (hr) 2010-10-06 2020-08-21 President And Fellows Of Harvard College Hidrogelovi koji stvaraju pore pogodni za injekcije, namijenjeni staničnim terapijama na bazi materijala
US8944067B2 (en) * 2010-12-15 2015-02-03 Kci Licensing, Inc. Targeted delivery of magnetically tagged active agents in combination with negative pressure wound therapy
US9764157B2 (en) 2011-01-17 2017-09-19 University Of Utah Research Foundation Methods, systems, and apparatus for reducing the frequency and/or severity of photophobic responses or for modulating circadian cycles
US10359552B2 (en) 2011-01-17 2019-07-23 University Of Utah Research Foundation Methods, systems, and apparatus for reducing the frequency and/or severity of photophobic responses or for modulating circadian cycles
WO2012177296A1 (en) 2011-01-17 2012-12-27 University Of Utah Research Foundation Apparatus and methods for reducing frequency or severity of photophobic responses or modulating circadian cycles
EP2683440B1 (de) 2011-03-10 2015-11-04 MagForce AG Computergestütztes simulationswerkzeug zur unterstützung bei der planung einer thermotherapie
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
ES2685327T3 (es) 2011-04-28 2018-10-08 President And Fellows Of Harvard College Armazones tridimensionales macroscópicos preformados inyectables para administración mínimamente invasiva
US20140093572A1 (en) * 2011-05-06 2014-04-03 Ut-Battelle, Llc Active materials for prevention and treatment of fouled surfaces
US9486512B2 (en) 2011-06-03 2016-11-08 President And Fellows Of Harvard College In situ antigen-generating cancer vaccine
CN102379762B (zh) * 2011-08-02 2015-03-25 上海微创医疗器械（集团）有限公司 一种带凹槽的生物可降解支架及其制备方法
JP5844902B2 (ja) 2011-08-10 2016-01-20 マグフォース アーゲー アルコキシシランでコーティングされた磁性ナノ粒子の凝集化
JP6042450B2 (ja) 2011-12-16 2016-12-14 ナノビオティックスＮａｎｏｂｉｏｔｉｘ 金属材料および酸化ハフニウム材料を含むナノ粒子、その製造および使用
ES2773895T3 (es) 2012-04-16 2020-07-15 Harvard College Composiciones de sílice mesoporosa para modular las respuestas inmunitarias
DK2906286T3 (en) 2012-10-11 2017-07-17 Nanocomposix Inc SILVER CHARACTER COMPOSITIONS AND PROCEDURES
WO2014085651A1 (en) * 2012-11-29 2014-06-05 The Johns Hopkins University A process for making iron oxide nanoparticle preparations for cancer hyperthermia
US20140219926A1 (en) * 2013-02-01 2014-08-07 The Trustees Of Dartmouth College Biodegradable Iron Oxide Nanoparticle Gel for Tumor Bed Therapy
WO2014124322A1 (en) 2013-02-08 2014-08-14 University Of Louisville Research Foundation, Inc. Nanoparticles for drug delivery
CN103203903A (zh) * 2013-03-25 2013-07-17 海龙核材科技（江苏）有限公司 一种电场磁场下响应的传感材料及其制备方法
SG10201710056UA (en) * 2013-06-04 2018-01-30 Fumedica Ag Cytotoxic substance for use in combination with radiotherapy in cancer treatment
AU2014283217A1 (en) * 2013-06-20 2015-12-24 Nanobiotix Compositions and methods for use in medical diagnosis
EP2823858A1 (en) 2013-07-12 2015-01-14 Brossel, Rémy System generating a constraint field, and medical device implementing the same
WO2015020936A1 (en) 2013-08-06 2015-02-12 Ut-Battelle, Llc Local thermal actuation of material surfaces via micro- and nanowire heating for the prevention of cellular attachment and biological fouling
US10281627B2 (en) 2013-11-15 2019-05-07 University Of Utah Research Foundation Nanoparticle light filtering method and apparatus
US10234608B2 (en) 2013-11-15 2019-03-19 University Of Utah Research Foundation Nanoparticle light filtering method and apparatus
CN103752849B (zh) * 2014-02-13 2016-02-24 华东理工大学 制备稳定纳米银的方法
US9814631B2 (en) * 2014-03-03 2017-11-14 Sambhu Choudhury Container for surgical absorbent articles
US20150297763A1 (en) 2014-04-17 2015-10-22 Boston Scientific Scimed, Inc. Devices and methods for therapeutic heat treatment
CN107073090A (zh) 2014-04-30 2017-08-18 哈佛学院董事会 结合的疫苗装置和杀死癌细胞的方法
CN103989552B (zh) * 2014-05-07 2015-10-28 江苏达胜伦比亚生物科技有限公司 一种医用水凝胶凉贴
CZ27466U1 (cs) * 2014-08-21 2014-11-10 Univerzita Tomáše Bati ve Zlíně Biomateriál na bázi hydrogelu citlivý na magnetické podněty
RU2616258C2 (ru) * 2014-11-10 2017-04-13 федеральное государственное автономное образовательное учреждение высшего образования "Московский физико-технический институт (государственный университет)" Способ получения полимерных наночастиц низкосиалированного эритропоэтина с высокой степенью сорбции для лечения неврологических заболеваний
WO2016123573A1 (en) 2015-01-30 2016-08-04 President And Fellows Of Harvard College Peritumoral and intratumoral materials for cancer therapy
US11150242B2 (en) 2015-04-10 2021-10-19 President And Fellows Of Harvard College Immune cell trapping devices and methods for making and using the same
JP2018516256A (ja) 2015-05-28 2018-06-21 ナノビオティックスＮａｎｏｂｉｏｔｉｘ 治療用ワクチンとしての使用のためのナノ粒子
WO2017037685A1 (en) * 2015-09-04 2017-03-09 University Of The Witwatersrand, Johannesburg Biodegradable implant
CN108289856A (zh) 2015-10-07 2018-07-17 波士顿科学国际有限公司 用以提高热疗的感应加热效率的具有不同居里温度的LaFeSiH磁性纳米粒子混合物
RU167739U1 (ru) * 2015-12-02 2017-01-10 Федеральное государственное бюджетное учреждение науки Красноярский научный центр Сибирского отделения Российской академии наук (ФГБУН КНЦ СО РАН) Нанодиски для разрушения опухолевых клеток
WO2017136837A1 (en) 2016-02-06 2017-08-10 President And Fellows Of Harvard College Recapitulating the hematopoietic niche to reconstitute immunity
AU2017295704B2 (en) 2016-07-13 2023-07-13 President And Fellows Of Harvard College Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
CN110418651A (zh) 2016-08-02 2019-11-05 哈佛学院院长等 用于调节免疫应答的生物材料
JP6968887B2 (ja) * 2016-09-08 2021-11-17 シェーファー・カーク・ゲーエムベーハー・ウント・コンパニー・カーゲーSchaefer Kalk Gmbh & Co. Kg 微細構造粒子を有するカルシウム塩含有複合粉末
EP3305334A1 (en) * 2016-10-06 2018-04-11 Universitätsklinikum Jena Magnetic composition and medical material for stimulating vascularisation in internal or external wound of the body
US10993910B2 (en) 2016-12-07 2021-05-04 Seoul National University R&Db Foundation Biopatch, bioheater, biosensor and bioelectronic patch device
CZ307237B6 (cs) * 2016-12-16 2018-04-18 Synthesia, A. S. Supramolekulární komplex oxycelulózové matrice s taxolovým derivátem s postupným uvolňováním taxolového derivátu a jeho použití
US20190350867A1 (en) * 2016-12-27 2019-11-21 Soon Kap Hahn Prevention of local tumor recurrence following surgery using sustained and/or delayed release of medicaments contained in micro-particles
US12396951B2 (en) 2016-12-27 2025-08-26 Upexmed Co. Ltd. Prevention of local tumor recurrence following surgery using sustainedand/or delayed release of medicaments contained in micro-particles
DE102017214576A1 (de) * 2017-08-21 2019-02-21 Universität Bielefeld Anorganisch-organischer Nanokomposit mit zellbiologischer und sensorischer Aktivität
RU181004U1 (ru) * 2017-11-14 2018-07-03 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Пластинчатый дентальный имплантат для многопозиционного протезирования
RU181003U1 (ru) * 2017-11-14 2018-07-03 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Пластинчатый дентальный имплантат для многопозиционного протезирования
RU181002U1 (ru) * 2017-12-25 2018-07-03 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Пластинчатый дентальный имплантат для многопозиционного протезирования
KR102200787B1 (ko) * 2017-12-29 2021-01-12 한경대학교 산학협력단 나노셀룰로오스를 이용한 습윤성 탄력붕대
CN108912628A (zh) * 2018-05-31 2018-11-30 苏州乔纳森新材料科技有限公司 一种插管用抗菌纳米材料的制备方法
WO2020061129A1 (en) 2018-09-19 2020-03-26 President And Fellows Of Harvard College Compositions and methods for labeling and modulation of cells in vitro and in vivo
JP2022514568A (ja) 2018-12-17 2022-02-14 プレジデント アンド フェローズ オブ ハーバード カレッジ 免疫系のモジュレーションのための生物工学的スキャフォールドおよびその使用
RU189268U1 (ru) * 2019-03-22 2019-05-17 Артем Олегович Бахметьев Акупунктурная игла
RU189308U1 (ru) * 2019-03-22 2019-05-21 Артем Олегович Бахметьев Трансдермальный пластырь
KR102372213B1 (ko) * 2019-09-09 2022-03-08 한국화학연구원 히알루론산 또는 그의 염 및 폴리페놀 화합물을 포함하는 수분해성 필름
JP2022549270A (ja) 2019-09-23 2022-11-24 プレジデント アンド フェローズ オブ ハーバード カレッジ バイオマテリアルベースの無抗原ワクチンおよびその使用
KR20220133893A (ko) 2020-01-31 2022-10-05 매그포스 아게 자성 알콕시실란-코팅된 금속 함유 나노입자를 포함하는 페이스트
CN111921003B (zh) * 2020-09-04 2022-06-03 东南大学 一种磁响应热疗可控降解栓塞微球及其制备方法与应用
CN112972779B (zh) * 2021-02-05 2022-07-12 武汉磁济科技有限公司 一种植入式柔性磁响应人工膀胱基体及其制造方法
CN112972778B (zh) * 2021-02-05 2022-05-27 华中科技大学 一种人工膀胱铁磁复合物及其制备方法
CN112933288B (zh) * 2021-02-08 2022-02-22 四川大学 兼具止血和术后抗肿瘤功能的交联止血海绵及其制备方法
US20230061188A1 (en) * 2021-08-30 2023-03-02 Apple Inc. Enhanced mems sensor embedded heater
DE102022115394A1 (de) 2022-06-21 2023-12-21 Rheinisch-Westfälische Technische Hochschule (Rwth) Aachen Implantat und Anordnung aufweisend eine Strahlungsquelle und ein Implantat

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001005586A1 (en) * 1999-07-16 2001-01-25 Wm. Marsh Rice University Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery
WO2004045652A2 (en) * 2002-11-15 2004-06-03 Politecnico Di Torino Biocompatible magnetic materials for the treatment of cancer by means of hyperthermia, and processes for their production
WO2006015317A2 (en) * 2004-07-30 2006-02-09 Acrymed, Inc. Antimicrobial devices and compositions
WO2006037113A2 (en) * 2004-09-28 2006-04-06 The Hong Kong University Of Science And Technology Multifunctional supramolecular hydrogels as biomaterials
DE102005016873A1 (de) * 2005-04-12 2006-10-19 Magforce Nanotechnologies Ag Nanopartikel-Wirstoff-Konjugate
WO2006125452A1 (en) * 2005-05-23 2006-11-30 Universite De Geneve Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH31064A (en) * 1990-09-07 1998-02-05 Nycomed As Of Nycoveten Polymers containing diester units.
US5411730A (en) 1993-07-20 1995-05-02 Research Corporation Technologies, Inc. Magnetic microparticles
DE4428851C2 (de) 1994-08-04 2000-05-04 Diagnostikforschung Inst Eisen enthaltende Nanopartikel, ihre Herstellung und Anwendung in der Diagnostik und Therapie
US7611533B2 (en) * 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
DE19614136A1 (de) 1996-04-10 1997-10-16 Inst Neue Mat Gemein Gmbh Verfahren zur Herstellung agglomeratfreier nanoskaliger Eisenoxidteilchen mit hydrolysebeständigem Überzug
JPH10328314A (ja) * 1997-06-02 1998-12-15 Nippon Electric Glass Co Ltd 温熱治療用セメント材料及び温熱治療用インプラント材
JPH10337335A (ja) * 1997-06-06 1998-12-22 Nippon Electric Glass Co Ltd 温熱治療用インプラント材
DE19726282A1 (de) 1997-06-20 1998-12-24 Inst Neue Mat Gemein Gmbh Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern
US20030073663A1 (en) * 1997-06-25 2003-04-17 David M Wiseman Bioabsorbable medical devices from oxidized polysaccharides
US6267782B1 (en) * 1997-11-20 2001-07-31 St. Jude Medical, Inc. Medical article with adhered antimicrobial metal
DE10059151C2 (de) 2000-11-29 2003-10-16 Christoph Alexiou Magnetische Partikel zur zielgerichteten regionalen Therapie und Verwendung derselben
US6527693B2 (en) * 2001-01-30 2003-03-04 Implant Sciences Corporation Methods and implants for providing radiation to a patient
EP1496860A1 (en) 2001-09-28 2005-01-19 Saoirse Corporation Localized non-invasive biological modulation system
DE10164309A1 (de) * 2001-12-28 2003-07-10 Fraunhofer Ges Forschung Verbesserte strukturiert-funktionale Bindematrices für Biomoleküle
US7101394B2 (en) * 2002-05-02 2006-09-05 Boston Scientific Scimed, Inc. Energetically-controlled delivery of biologically active material from an implanted medical device
AU2003301251A1 (en) * 2002-10-15 2004-05-04 Ferx Incorporated Magnetically guided particles for radiative therapies
DE10350248A1 (de) 2003-10-28 2005-06-16 Magnamedics Gmbh Thermosensitive, biokompatible Polymerträger mit veränderbarer physikalischer Struktur für die Therapie, Diagnostik und Analytik
US20070196281A1 (en) 2003-12-31 2007-08-23 Sungho Jin Method and articles for remote magnetically induced treatment of cancer and other diseases, and method for operating such article
WO2005070471A2 (en) 2004-01-20 2005-08-04 Alnis Biosciences, Inc. Articles comprising magnetic material and bioactive agents
FR2889449B1 (fr) 2005-08-05 2011-06-10 Khorionyx Preparations implantables
DE102005039579B4 (de) 2005-08-19 2022-06-30 Magforce Ag Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen
WO2007095454A2 (en) * 2006-02-10 2007-08-23 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Carbon-encased metal nanoparticles and sponges, methods of synthesis, and methods of use
JP2010516705A (ja) * 2007-01-19 2010-05-20 トリトン バイオシステムズ、インク． 温熱療法におけるサセプタとその使用法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001005586A1 (en) * 1999-07-16 2001-01-25 Wm. Marsh Rice University Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery
WO2004045652A2 (en) * 2002-11-15 2004-06-03 Politecnico Di Torino Biocompatible magnetic materials for the treatment of cancer by means of hyperthermia, and processes for their production
WO2006015317A2 (en) * 2004-07-30 2006-02-09 Acrymed, Inc. Antimicrobial devices and compositions
WO2006037113A2 (en) * 2004-09-28 2006-04-06 The Hong Kong University Of Science And Technology Multifunctional supramolecular hydrogels as biomaterials
DE102005016873A1 (de) * 2005-04-12 2006-10-19 Magforce Nanotechnologies Ag Nanopartikel-Wirstoff-Konjugate
WO2006125452A1 (en) * 2005-05-23 2006-11-30 Universite De Geneve Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant

Also Published As

Publication number Publication date
WO2009100716A3 (de) 2010-09-23
EP2249804A2 (de) 2010-11-17
RU2010136311A (ru) 2012-03-20
EP2249804B1 (de) 2016-12-14
PL2249804T3 (pl) 2017-07-31
WO2009100716A2 (de) 2009-08-20
US20110223255A1 (en) 2011-09-15
PT2249804T (pt) 2017-03-20
IL207137A0 (en) 2010-12-30
JP2011511684A (ja) 2011-04-14
DK2249804T3 (en) 2017-02-27
KR101581973B1 (ko) 2015-12-31
CA2712832A1 (en) 2009-08-20
MX2010008806A (es) 2010-12-21
DE112009000905A5 (de) 2011-01-20
IL207137A (en) 2015-02-26
ES2619509T3 (es) 2017-06-26
RU2524644C2 (ru) 2014-07-27
SG188146A1 (en) 2013-03-28
BRPI0906611A8 (pt) 2019-01-29
CA2712832C (en) 2016-05-17
JP5649455B2 (ja) 2015-01-07
AU2009214533A1 (en) 2009-08-20
KR20100117602A (ko) 2010-11-03
DE102008008522A1 (de) 2009-08-13
BRPI0906611A2 (pt) 2015-07-14
CN101938993A (zh) 2011-01-05

Similar Documents

Publication Publication Date Title
CA2712832C (en) Implantable products comprising nanoparticles
Cheng et al. Injectable adhesive hemostatic gel with tumor acidity neutralizer and neutrophil extracellular traps lyase for enhancing adoptive NK cell therapy prevents post-resection recurrence of hepatocellular carcinoma
JP5037490B2 (ja) ナノ粒子／活性成分結合体
EP2531220B1 (en) Active scaffolds for on-demand drug and cell delivery
US20160331853A1 (en) Compositions for radiotherapy and uses thereof
US20070292495A1 (en) Nanoshells for drug delivery
CN104159573A (zh) 用于控制出血和药物递送的纳米粒子
CN105979978A (zh) 功能化的光滑医疗器械涂层
Wang et al. Trifunctional Fe3O4/CaP/Alginate core–shell–corona nanoparticles for magnetically guided, pH-responsive, and chemically targeted chemotherapy
CN101287507A (zh) 用于淋巴靶向的方法和装置
US20170333304A1 (en) Hydrogel Particles, Compositions, and Methods
US10925852B2 (en) Talc-bound compositions and uses thereof
CN111228212A (zh) 载药可注射植入原位水凝胶
WO2017196986A1 (en) Dendrimer-drug conjugates, hydrogel compositions, and methods
US20150110882A1 (en) Multifunctional metallic nanostructure and method for manufacturing the same
Ficai et al. Advances in cancer treatment: role of nanoparticles
WO2018022929A1 (en) Gel-bound compositions for radiotherapy and uses thereof
Patel et al. Targeting aspects of hydrogels in drug delivery
WO2025013818A1 (ja) ゼラチン誘導体の粒子を含む粉体、およびその医療における応用
Fratila Nanomaterials in biotechnology–Current topics
이혜리 et al. Targeted MRI Contrast Agent Based on Hyperbranched Lipopolymer Hybrids
WO2019195466A1 (en) Compositions for radiotherapy and uses therof

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: NANOTHERM THERAPEUTICS GMBH

Free format text: FORMER OWNER(S): MAGFORCE AG